SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPDR S&P 500 ETF Trust is trending intensely as news circulates regarding a criminal investigation into the Federal Reserve Chair, sparking widespread debate on the independence of monetary policy. Community sentiment is polarized, with some anticipating significant market volatility while others view it as a politically motivated event poised for a rapid rebound. Investors are closely monitoring the situation for broader implications on market stability and the direction of future rates.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

The tech-heavy QQQ is trending amid swirling uncertainty from a reported federal probe into Fed Chair Powell, sparking community debate over market resilience versus potential downside. Investors are also digesting President Trump's recent actions, including a proposed credit card interest rate cap and escalating geopolitical tensions, adding complexity to the current all-time high market environment.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is capturing significant market attention, primarily driven by reports of a criminal investigation into the Fed Chair and heightened global geopolitical tensions. The community is debating whether gold's ascent signals a crucial safe-haven move amidst currency debasement and instability, or if it represents a manipulated bull trap ahead of commodity index rebalancing. This dynamic interplay of systemic risk and central bank actions is generating strong interest in the metal's immediate trajectory.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is experiencing a surge in interest amid high-level discussions concerning Greenland's critical mineral resources, particularly its massive Tanbreez rare earth project. The community is actively discussing potential strategic deals and government investments aimed at securing a vital non-Chinese supply chain, fueling strong bullish sentiment and anticipation of significant revaluation.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is seeing heightened investor attention following recent positive FDA feedback that significantly de-risked its lead asset, Sonelokimab, for a key inflammatory skin disease, validating its 'best-in-class' potential. This regulatory clarity has intensified community discussions around accelerated timelines and fueled widespread speculation about an imminent buyout, with many anticipating a significant competitive offer from major pharmaceutical players.

Volatility Shares Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

Geopolitical events, including military actions in Venezuela and upcoming Supreme Court decisions on tariffs, are sparking intense community debate around potential market volatility. Many traders are speculating if these catalysts will finally trigger a significant 'spike' in this 2x long VIX futures ETF, while others caution against its inherent decay and contango, branding it a 'broken instrument' unsuitable for long-term holds amidst prevailing broader market strength.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is trending significantly higher, defying expectations of a rebalancing selloff from commodity indices, as the community cites persistent physical shortages and silver's critical mineral designation. Discussions are rife with anticipation of a massive short squeeze and new all-time highs, while some voices warn of an overextended market and imminent retracement. This intense debate underscores silver's dual role as a precious metal and essential industrial component.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Holdings Inc

Ondas Holdings is drawing significant attention after a substantial stock and warrant offering to an institutional investor at a premium, which the community interprets as a strong endorsement for its strategic expansion. This capital injection is sparking broad discussion about potential acquisitions and the company's accelerating role in the global drone and counter-drone defense and security markets. Investors widely view this as positioning Ondas as a leader in a rapidly evolving technological landscape.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending amid heightened uncertainty surrounding its potential acquisition of Warner Bros. Discovery, amplified by a competing bid and recent analyst adjustments. The community is sharply divided, with many seeing the current suppressed share price as an attractive buying opportunity ahead of upcoming earnings, while others express caution regarding the deal's financial implications and broader market sentiment.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital (APLD) is trending following strong earnings that highlighted significant revenue growth and its strategic position in solving critical power and infrastructure bottlenecks for the burgeoning AI sector. The community is actively discussing impending hyperscaler contracts and potential short-squeeze dynamics, reflecting strong bullish sentiment regarding the company's future growth in the AI infrastructure space.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MBX Biosciences (NASDAQ:MBX) Trading Down 8.4% - Here's Why

MBX Biosciences (NASDAQ:MBX) Shares Down 8.4% - Time to Sell...

MBX Biosciences (NASDAQ:MBX) Stock Price Down 5.8% - Here's What Happened

MBX Biosciences (NASDAQ:MBX) Stock Price Down 5.8% - Should You Sell...

MBX Biosciences (NASDAQ:MBX) Reaches New 12-Month High - Still a Buy?

MBX Biosciences (NASDAQ:MBX) Hits New 12-Month High - What's Next...

MBX Biosciences (NASDAQ:MBX) Stock Price Up 10.8% - Still a Buy?

MBX Biosciences (NASDAQ:MBX) Stock Price Up 10.8% - What's Next...

MBX Biosciences (NASDAQ:MBX) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of MBX Biosciences from a "sell" rating to a "hold" rating in a research note on Sunday...

EcoR1 Capital LLC Lowers Holdings in MBX Biosciences, Inc. $MBX

EcoR1 Capital LLC trimmed its holdings in MBX Biosciences, Inc. (NASDAQ:MBX - Free Report) by 8.7% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission...

MBX Biosciences (NASDAQ:MBX) Lowered to Sell Rating by Wall Street Zen

Wall Street Zen cut MBX Biosciences from a "hold" rating to a "sell" rating in a research note on Saturday...

Walleye Capital LLC Increases Stock Holdings in MBX Biosciences, Inc. $MBX

Walleye Capital LLC grew its stake in MBX Biosciences, Inc. (NASDAQ:MBX - Free Report) by 116.5% during the second quarter, according to the company in its most recent disclosure with the Securities...

MBX Biosciences, Inc. $MBX Stake Increased by Stempoint Capital LP

Stempoint Capital LP lifted its stake in MBX Biosciences, Inc. (NASDAQ:MBX - Free Report) by 46.0% in the second quarter, according to its most recent disclosure with the Securities and Exchange...

MBX Biosciences (NASDAQ:MBX) Shares Down 5.6% - Should You Sell?

MBX Biosciences (NASDAQ:MBX) Stock Price Down 5.6% - Here's Why...

MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders. Its product candidates and programs include MBX 2109, MBX 1416, and obesity portfolio. The company was founded by Peter Kent Hawryluk and Richard D. DiMarchi in August 2018 and is headquartered in Carmel, IN.

MBX Biosciences Inc.

Yes — Rates Move Meaningfully Lower

Short-Term Dip, No Lasting Impact

No — Mostly Political Noise

Other – Comment Below

President Trump says he’s directing $200 billion into mortgage bond purchases to bring down rates and improve housing affordability. With questions around execution, authority, and real market impact, do you think this move will actually lower mortgage rates in 2026?

Will Trump’s Mortgage Bond Plan Actually Lower Rates in 2026?

Current Price	$31.67
Prev Close	$30.72
Open	$30.96
Dividend Yield	0.00%
50-Day Moving Average	$28.49
Beta	1.70
Avg. Volume	867,563.50
PE Ratio	-13.23

52-Week High	$35.55
52-Week Low	$4.81
Market Capitalization	$1.38B
EPS (Annual)	-$1.85
Price to Book	3.65
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

MBX
MBX Biosciences Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MBX News

MBXMBX Biosciences Inc.